Grifols, S.A. (NASDAQ:GRFS) Receives $13.53 Consensus Target

Grifols, S.A. (NASDAQ:GRFS) Receives $13.53 Consensus Target Price from Analysts

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […]

Related Keywords

, Morgan Stanley , Advisor Group Holdings Inc , Barclays , Grifols Company Profile , Jefferies Financial Group , Quadrant Capital Group , Get Rating , Financial Advisors , Group Holdings , Capital Group , Creative Planning , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Grifols , Nasdaq Grfs , Grfs , Medical , Ratings , Consensus ,

© 2025 Vimarsana